Who is sponsoring NCT02585271?

NCT02585271 is sponsored by Xuzhou Central Hospital.

What drugs are being tested in NCT02585271?

Interventions in NCT02585271: Transanal decompression tube, Stent.

What condition does NCT02585271 study?

NCT02585271 studies Colonic Cancer, Rectal Cancer.

Is NCT02585271 still recruiting?

NCT02585271 is currently terminated. Last updated 5 July 2019.

Last reviewed 2019-07-05 · How we verify

NCT02585271

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Transanal Decompression Tube Versus Stent for Acute Malignant Left-sided Colonic and Rectal Obstruction

Terminated NA Last updated 5 July 2019

What this trial tests

NA trial testing Transanal decompression tube in Colonic Cancer in 8 participants. Terminated before completion.

Timeline

1 October 2015

Primary endpoint
1 June 2016

1 June 2016

Quick facts

Lead sponsor	Xuzhou Central Hospital
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	8
Start date	1 October 2015
Primary completion	1 June 2016
Estimated completion	1 June 2016
Sites	1 location across China

Drugs / interventions tested

Transanal decompression tube
Stent

Conditions studied

Colonic Cancer — all drugs for Colonic Cancer →
Rectal Cancer — all drugs for Rectal Cancer →

Sponsor

Xuzhou Central Hospital

Who can join

Adults 18 to 80, any sex, with Colonic Cancer or Rectal Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to compare the clinical outcomes of transanal decompression tube as a bridge to surgery with stent as a bridge to surgery for acute malignant left-sided colonic and rectal obstruction.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Colonic Cancer

Currently open trials in the same condition.

NCT05434026 — Chinese Colorectal Cancer Database · recruiting
NCT04084249 — ctDNA-guided Surveillance for Stage III CRC, a Randomized Intervention Trial · NA · active not recruiting
NCT00600496 — A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-14288 · Phase 1 · active not recruiting

Other Xuzhou Central Hospital trials

Trials by the same sponsor.

NCT06126289 — CSF Single-cell Sequencing and Proteomics of Chronic Postsurgical Pain in Patients With Lower Limb Fractures · unknown
NCT06136663 — Prevalence and Risk Factors for Postsurgical Pain After the Open Reduction and Internal Fixation of Lower Limbs. · unknown
NCT06050096 — DCB Treatment in CTO Guided by IVUS · unknown
NCT06395961 — Effect of New High Ankle Block on Wound Healing After the Operation of Debridement of Diabetes Foot · NA · enrolling by invitation
NCT05772026 — Plasma Proteomics in Patients With Postoperative Delirium · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02585271 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Xuzhou Central Hospital
Last refreshed: 5 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02585271.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing